| Literature DB >> 23222802 |
Federico Ferreres1, Graciliana Lopes, Angel Gil-Izquierdo, Paula B Andrade, Carla Sousa, Teresa Mouga, Patrícia Valentão.
Abstract
Purified phlorotannin extracts from four brown seaweeds (Cystoseira nodicaulis (Withering) M. Roberts, Cystoseira tamariscifolia (Hudson) Papenfuss, Cystoseira usneoides (Linnaeus) M. Roberts and Fucus spiralis Linnaeus), were characterized by HPLC-DAD-ESI-MSn. Fucophloroethol, fucodiphloroethol, fucotriphloroethol, 7-phloroeckol, phlorofucofuroeckol and bieckol/dieckol were identified. The antioxidant activity and the hyaluronidase (HAase) inhibitory capacity exhibited by the extracts were also assessed. A correlation between the extracts activity and their chemical composition was established. F. spiralis, the species presenting higher molecular weight phlorotannins, generally displayed the strongest lipid peroxidation inhibitory activity (IC₅₀ = 2.32 mg/mL dry weight) and the strongest HAase inhibitory capacity (IC₅₀ = 0.73 mg/mL dry weight). As for superoxide radical scavenging, C. nodicaulis was the most efficient species (IC₅₀ = 0.93 mg/mL dry weight), followed by F. spiralis (IC₅₀ = 1.30 mg/mL dry weight). These results show that purified phlorotannin extracts have potent capabilities for preventing and slowing down the skin aging process, which is mainly associated with free radical damage and with the reduction of hyaluronic acid concentration, characteristic of the process.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23222802 PMCID: PMC3528125 DOI: 10.3390/md10122766
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Extracted Ion Chromatogram (EIC) of purified phlorotannin extracts of F. spiralis, C. usneoides, C. tamariscifolia and C. nodicaulis. [M + H]+ (m/z): 1, 499; 2, 747; 3–5, 871; 6–8, 995; 9 and 11, 375; 10, 499; 12, 623; 13, 499; 14, 497; 15–17, 499; 18–19, 497; 20–21, 603; 22, 743.
Figure 2UV chromatograms of the purified phlorotannin extracts of F. spiralis, C. usneoides, C. tamariscifolia and C. nodicaulis, recorded at 280 nm. Identity of compounds as in Figure 1.
Figure 3Hypothetical structure of the identified phlorotannins: Identity of compounds as in Figure 1.
Figure 4+MS2[M + H]+ analysis of (A) compound 9 from C. usneoides and (B) compound 6 from F. spiralis.
Rt, UV and MS: [M + H]+, +MS2[M + H]+ data of compounds from F. spiralis (1–8), C. usneoides (9–12), C. tamariscifolia (13–14) and C. nodicaulis (15–22) a.
| UV (nm) | [M + H]+,
| +MS2[M + H]+,
| ||
|---|---|---|---|---|
|
| 9.0 | — | 499 | 481 (80, −18), 439 (53, −18 − 42), 392 (25), 373 (35, −126), 355 (100, −126 − 18) |
|
| 20.8 | 248, 268sh | 747 | 729 (45, −18), 711 (70, −36), 585 (25, −126 − 36), 571 (35, −126 – 36 − 14), 220 (100) |
|
| 22.7 | 244, 270sh | 871 | 853 (100, −18), 835 (60, −36), 727 (30, −126 − 18), 709 (55, −126 − 36), 681 (30), 641 (12), 585 (15), 570 (7), 484 (35) |
|
| 23.6 | — | 871 | 853 (100, −18), 835 (76, −36), 727 (38, −126 − 18), 709 (17, −126 − 36), 603 (22), 585 (20), 517 (9), 403 (7), 310 (4) |
|
| 24.0 | 274sh | 871 | 853 (67, −18), 835 (100, −36), 725 (25), 709 (55, −126 − 36), 694 (58), 681 (21), 569 (17), 551 (18), 435 (20) |
|
| 24.4 | 272sh | 995 | 977 (100, −18), 959 (45, −36), 851 (3, −126 − 18), 833 (15, −126 − 36), 709 (26, −126 − 124 − 36), 692 (15) |
|
| 25.0 | 274sh | 995 | 977 (100, −18), 959 (27, −36), 869 (7, −126), 851 (8, −126 − 18), 833 (12, −126 − 36), 709 (9, −126 − 124 − 36), 692 (6) |
|
| 25.6 | 274sh | 995 | 977 (100, −18), 959 (8, −36), 851 (19, −126 − 18), 833 (14, −126 − 36), 709 (12, −126 − 124 − 36), 692 (14) |
|
| 22.5 | 270 | 375 | 357 (44, −18), 339 (2, −36), 249 (42, −126), 235 (100, −126 − 14), 231 (74, −126 − 18), 217 (43), 127 (75, floroglc + H) |
|
| 25.0 | — | 499 | 481 (80, −18), 453 (18, −18 − 28), 419 (70), 372 (33, −127), 359 (30, −126 − 14), 355 (100, −126 − 18), 301 (42), 179 (43) |
|
| 25.2 | — | 375 | 357 (23, −18), 339 (7, −36), 249 (40, −126), 235 (100, −126 − 14), 317 (33), 127 (57, floroglc + H) |
|
| 26.8 | — | 623 | 605 (33, −18), 577 (18, −18 − 28), 523 (50), 497 (2, −126), 483 (12, −126 − 14), 479 (10, −126 − 18), 337 (44), 231 (100) |
|
| 13.0 | — | 499 | 481 (49, −18), 411 (29), 397 (28), 395 (25), 359 (25, −162 − 14), 356 (17), 250 (16), 231 (100), 166 (33) |
|
| 14.9 | — | 497 | 479 (9, −18), 462 (24), 451 (30, −18 − 28), 386 (48), 368 (70), 351 (34), 258 (100), 240 (38), 222 (37) |
|
| 13.5 | — | 499 | 481 (70, −18), 373 (24, −126), 355 (70, −126 − 18), 341 (52, −126 − 18 − 14), 291 (33), 272 (70), 249 (100) |
|
| 15.8 | — | 497 | 479 (100, −18), 463 (24), 451 (31, −18 − 28), 368 (8), 351 (45), 298 (14), 258 (41) |
|
| 16.7 | — | 497 | 479 (83, −18), 462 (100), 452 (8), 435 (18), 385 (32), 368 (74), 351 (23), 258 (53) |
|
| 24.5 | — | 603 | 559 (100, −44), 482 (94), 464 (78) |
|
| 24.7 | — | 499 | 481 (100, −18), 368 (38), 247 (25), 242 (25) |
|
| 25.2 | — | 499 | 462 (9), 368(100), 334 (12) |
|
| 28.1 | — | 743 | 725 (45, −18), 715 (80, −28), 701 (97, −42), 685 (10), 633 (100), 600 (33) |
|
| 30.5 | — | 603 | 585 (100, −18), 523 (15), 458 (17), 368 (56), 301 (30) |
a Main observed fragments. Other ions were found, but they have not been included.
Figure 5Activity of purified phlorotannin extracts against superoxide radical (A) and lipid peroxidation (B). Results are expressed as percentage relative to control (mean ± standard deviation of three independent assays).
Biological activity of purified phlorotannin extracts a.
| Samples | Assays | |||||
|---|---|---|---|---|---|---|
| Superoxide radical scavenging | Lipid peroxidation inhibition | HAase inhibition | ||||
|
| 2.73 (0.30) | 7.55 (0.02) | 3.3 (0.12) | |||
|
| 4.02 (0.68) | >9.10 | 2.51 (0.22) | |||
|
| 1.30 (0.04) | 2.32 (0.08) | 0.73 (0.06) | |||
|
| 0.93 (0.11) | 8.52 (0.08) | 1.34 (0.04) | |||
a IC50 values (mg/mL, dry weight), represented as mean (standard deviation) of three assays, performed in triplicate.
Figure 6Inhibitory activity of purified phlorotannin extracts against hyaluronidase. Results are expressed as percentage of hyaluronidase inhibition relative to control (mean ± standard deviation of three independent assays).